Table of Contents
<< Previous Issue | May 2010 (Vol: 2010, Issue: 5) | Next Issue >> |
- Section: Joint Venture
-
AstraZeneca and TB Alliance Collaborate to Address TB
- Section: Licensing
-
Novartis and Array Agree MEK Inhibitor Deal Worth up to USD 467 M
-
Glenmark Inks Two Progressive Deals
-
Orchid in licensing deal with Alvogen
-
Clovis Oncology and Avila Therapeutics to Collaborate on Novel Lung Cancer Drug
- Section: Mergers & Acquisitions
-
Hospira and Javelin Pharmaceuticals Enter Into Definitive Merger Agreement
-
GlaxoSmithKline Strengthens Presence in Emerging Asian Markets
-
Valeant Pharma acquires Aton Pharma for USD 318 M
-
Sandoz to acquire respiratory firm Oriel
-
Abbott Enters Into Deals with Piramal and Zydus Cadila to Accelerate Growth in Emerging Markets
-
Intercell Acquires Monoclonal Antibody Assets from Cytos